Director, GI/Liver Biomarkers & Translational Research

Gilead Sciences, Inc.

Where
United States - California - Foster City
Pay
$243K a year

Posted 13 days ago· Checked live at Gilead Sciences, Inc. 4 days ago

Live.Open on the employer's own site.

See how you score for this job

One sentence and your resume. We score it against what Gilead Sciences, Inc. asks for, line by line.

See my score
Is this job still open?
Yes. We checked it live on Gilead Sciences, Inc.'s own hiring page 4 days ago.
What is the job?
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe.
What does it pay?
$243K a year, as the posting states.
Our verdict
Live. Open on the employer's own site.

What the job is

At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe.

Key Responsibilities

  • Own and continuously evolve the integrated GI/IBD and liver biomarker and translational strategy across multiple clinical-stage assets, aligning evidence generation with disease-area, asset, regulatory and portfolio objectives.
  • Lead the most complex programs from early clinical development through Phase II/III, defining decision criteria for target engagement, dose, proof-of-concept, patient selection, response, safety, differentiation and lifecycle opportunities.
  • Provide hands-on scientific leadership for analysis and interpretation of blood, stool, intestinal and liver tissue, endoscopic, histologic, imaging, pathology and multi-omic datasets.
  • Create cross-asset frameworks for forward and reverse translation, including integrated biopsy strategies and analyses of response, resistance, relapse, patient heterogeneity and mechanisms of action.
  • Lead biomarker and translational contributions to protocols, analysis plans, investigator brochures, clinical study reports, briefing documents, regulatory submissions and health authority interactions.
  • Partner with senior leaders across Clinical Development, Research, Clinical Pharmacology, Biostatistics, Bioinformatics, Diagnostics, Clinical Operations and Regulatory; clearly articulate scientific opportunities, uncertainties, trade-offs and recommendations.
  • Oversee biomarker execution, assay and vendor strategy, budgets, timelines, resources and delivery across several concurrent studies; anticipate risks and establish mitigation plans.
  • Establish collaborations with investigators, KOLs, pathologists, consortia and technology partners; represent GI/liver biomarker science at advisory boards, scientific meetings and external forums.
  • Lead publication and evidence-dissemination strategy and maintain an active external scientific presence that strengthens the credibility and differentiation of the portfolio.
  • Develop direct reports and matrix team members, elevate scientific and operational standards, and build reusable capabilities, analytics and best practices across the biomarker organization.
  • Contribute to portfolio prioritization, resource planning and long-range capability strategy; present clear business and scientific cases to governance and executive audiences.

Basic Qualifications

  • PhD, MD, MD/PhD, PharmD or equivalent advanced degree in immunology, gastroenterology, hepatology, inflammation biology, translational medicine, pharmacology or a related discipline.
  • Typically 12+ years of relevant biotechnology, pharmaceutical, clinical development or human translational research experience, including substantial leadership of clinical-stage biomarker programs.
  • Demonstrated ownership of biomarker and translational strategy across multiple complex programs, with clear examples of influencing dose, proof-of-concept, patient population, go/no-go, regulatory or portfolio decisions.
  • Recognized scientific expertise in human immunology and immune-mediated inflammatory disease, with strong GI/IBD expertise and meaningful knowledge of liver inflammation, injury and/or fibrosis.
  • Proven and sustained scientific productivity and innovation, demonstrated by impactful peer-reviewed publications, patents, influential translational or clinical datasets, invited presentations, external recognition, major development milestones or comparable achievements.
  • Extensive experience with biomarker-rich clinical trials, regulated development, assay externalization, clinical sample operations, complex data integration and regulatory documentation or interactions.
  • Demonstrated ability to lead and influence senior stakeholders, independently structure multiple large-scale assignments, manage resources and communicate cohesive strategy to governance and executive audiences.
  • Track record of mentoring and developing scientists and elevating standards across cross-functional or matrix teams.

Preferred Qualifications

  • Direct leadership of biomarker strategies in Crohn’s disease and/or ulcerative colitis, including endoscopic, histologic, intestinal tissue, blood and stool assessments.
  • Experience in liver inflammation, fibrosis, noninvasive biomarkers, imaging and/or liver histopathology.
  • Experience spanning first-in-human through registrational development and direct participation in FDA, EMA or other health authority interactions.
  • Expertise integrating single-cell, spatial, transcriptomic, proteomic, cellular, genetic, pathology, imaging and clinical data into portfolio decisions.
  • Knowledge of companion diagnostic strategy and evidence requirements.
  • Established relationships with investigators, KOLs, consortia or technology innovators in GI/IBD, liver disease or human translational immunology.

Leadership Profile

A scientifically distinguished, hands-on portfolio leader who sets a compelling direction, operates with rigor and creativity, mobilizes teams through influence, develops talent and consistently converts complex evidence into development and business impact.

The salary range for this position is: $243,100.00 - $314,600.00. Gilead considers a variety of factors when determining base compensation, including experience, qualifications, and geographic location. These considerations mean actual compensation will vary. This position may also be eligible for a discretionary annual bonus, discretionary stock-based long-term incentives (eligibility may vary based on role), paid time off, and a benefits package. Benefits include company-sponsored medical, dental, vision, and life insurance plans*.

For additional benefits information, visit

https://www.gilead.com/careers/compensation-benefits-and-wellbeing

  • Eligible employees may participate in benefit plans, subject to the terms and conditions of the applicable plans.